A Multicentric Experience On Living Donor Liver Transplantation In Coronavirus Disease 2019 Hotspots In India

Joy Varghese,Selvakumar Malleeswaran,Rajanikanth V Patcha,Ellango Appusamy,Perumal Karnan,Dharmesh Kapoor,Venugopal Kota, Chandhan Kumar Kedarisetty,Balbir Singh,Prashantha S Rao,Raghavendra Babu Yalakanti,Ravi Mohanka,Anurag Shrimal,Vinayak Nikam,Karan Kumar,Sunil D Shenvi, Venugopal Bhaskaran Pillai,Nigel D Heaton

LIVER TRANSPLANTATION（2021）

引用 8|浏览19

暂无评分

摘要

As of August 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected more than 213 countries, leading to more than 18 million cases and 690,000 deaths. India is the second most affected country, with the majority of cases in metropolitan cities, such as Mumbai, New Delhi, Chennai, and Bengaluru. There is limited literature on the outcomes and safety of performing living donor liver transplantation (LDLT) in coronavirus disease 2019 (COVID-19) epicenters.

查看译文

关键词

LDLT,SARS-CoV-2,chronic liver disease,liver transplant

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要